Genetic Causes of Male Infertility
Klinefelter Syndrome, Y-Chromosome Microdeletions, and CFTR Mutations
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (genetic conditions)
Reference only. Not medical advice.
What can go wrong
The key clinical risk is missing a diagnosis that changes management: for example, complete AZFa or AZFb deletion predicts that surgical sperm retrieval will fail, sparing a man a futile operation. Genetic causes are also heritable, AZFc deletions pass to all sons via ICSI, and a CFTR-mutation carrier should have his partner screened to avoid a child with cystic fibrosis. Some men with Klinefelter can have sperm retrieved by micro-TESE, but success declines with age, making timing important.
This is something to take to a clinician. The Atlas can tell you what is known about genetic causes of male infertility in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A meaningful fraction of severe male infertility has a genetic basis that changes prognosis, treatment, and the genetic counseling a couple needs. The three best-characterized categories are Klinefelter syndrome (47,XXY, the most common chromosomal cause of male infertility), Y-chromosome microdeletions of the AZF regions (which predict success or failure of surgical sperm retrieval), and CFTR mutations (cystic fibrosis gene), which cause congenital bilateral absence of the vas deferens. Men with non-obstructive azoospermia or severe oligospermia should have karyotype, Y-microdeletion testing, and, where relevant, CFTR analysis.
Why severe oligospermia or azoospermia warrants a karyotype and gene panel before anything else.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
In Klinefelter syndrome, the extra X chromosome leads to progressive testicular fibrosis and hyalinization, usually causing azoospermia, small firm testes, and hypergonadotropic hypogonadism (high FSH/LH, low testosterone). Y-chromosome microdeletions remove genes in the azoospermia factor (AZF) regions essential for spermatogenesis; the specific region deleted predicts whether sperm can be found surgically. CFTR mutations disrupt the chloride channel and cause defective development of the vas deferens, producing obstructive azoospermia with otherwise normal sperm production.
What it does to fertility
Genetic diagnosis reframes the entire fertility plan. Klinefelter men have hypogonadism and usually need both fertility management (micro-TESE before testosterone therapy if possible) and, separately, testosterone replacement for the hypogonadism itself, a place where the TRT-fertility conflict is acute. Y-microdeletion results determine whether surgery is even worth attempting, and CFTR findings demand partner screening to protect the offspring.
What people get wrong
Often saidAzoospermia always means no biological children are possible
ActuallyMany men with non-obstructive azoospermia, including some with Klinefelter or AZFc deletion, have sperm retrievable by micro-TESE for use in ICSI.
Often saidGenetic testing is optional in severe male infertility
ActuallyKaryotype and Y-microdeletion testing are standard of care for non-obstructive azoospermia and severe oligospermia because results change prognosis and prevent futile surgery and heritable harm.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
Klinefelter syndrome was described by Harry Klinefelter in 1942 and karyotypically defined as 47,XXY in 1959. The azoospermia-factor concept emerged in the 1970s and was molecularly mapped to AZF regions in the 1990s. The CFTR-CBAVD link, reported in the mid-1990s, connected andrology to cystic-fibrosis genetics and reshaped counseling for couples pursuing ICSI.
At a glance
- Klinefelter karyotype
- 47,XXY (most common chromosomal cause)
- Klinefelter prevalence
- ~1 in 500-1,000 male births
- Y-microdeletion regions
- AZFa, AZFb, AZFc
- AZFa/AZFb complete deletion
- Predicts failed sperm retrieval
- AZFc deletion
- Sperm sometimes retrievable; heritable to sons
- CFTR mutations
- Cause congenital bilateral absence of the vas deferens (CBAVD)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Genetic Causes of Male Infertility. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Lanfranco et al., Klinefelter review, Lancet2004
Defined the reproductive phenotype of Klinefelter syndrome and the emerging role of micro-TESE for sperm retrieval
EAA/EMQN best-practice guidelines, Y-microdeletion testingUpdated periodically
Standardized AZF region testing and its prognostic use for sperm retrieval
Chillon et al., CFTR and CBAVD, NEJM1995
Established the association between CFTR mutations and congenital bilateral absence of the vas deferens